Excellerate Bioscience Limited
Research and experimental development on biotechnology · Nottingham
ActiveUnited KingdomIncorporated 2016Private Limited Company
Financial position
Accounts to 2025-06-30 · GBP · Company accounts
Net assets
£2,773,629
Cash
£1,651,692
Turnover
—
Profit / loss
—
Current assets
£2,499,987
Creditors < 1 year
£522,419
Equity
£2,773,629
Average employees
31
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2025-06-30Company | 2024-06-30Company | 2023-06-30Company | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-05-31 |
|---|---|---|---|---|---|---|---|---|---|
| Balance sheet | |||||||||
| Net assets | £2,773,629 | £1,927,643 | £1,545,068 | £912,989 | £576,919 | £295,213 | £534,912 | £281,161 | £216,927 |
| Equity | £2,773,629 | £1,927,643 | £1,545,068 | £912,989 | £576,919 | £295,213 | £534,912 | £281,161 | £216,927 |
| Assets | |||||||||
| Property, plant & equipment | £796,061 | £687,055 | £663,064 | £306,955 | £271,454 | £201,498 | £398,111 | £243,384 | £127,515 |
| Current assets | £2,499,987 | £1,887,390 | £1,203,042 | £1,002,918 | £670,126 | £389,009 | £412,878 | £240,822 | £283,360 |
| Cash at bank | £1,651,692 | £1,633,420 | £967,068 | £846,397 | £635,538 | £331,145 | £125,395 | £145,586 | £225,694 |
| Debtors | £848,295 | £253,970 | £235,974 | £156,521 | £34,588 | £57,864 | £287,483 | £95,236 | £57,666 |
| Liabilities | |||||||||
| Creditors within one year | £522,419 | £646,802 | £321,038 | £362,356 | £324,661 | £295,294 | £276,077 | £203,045 | £193,948 |
| Creditors after one year | — | — | — | £34,528 | £40,000 | — | — | — | — |
| Net current assets | £1,977,568 | £1,240,588 | £882,004 | £640,562 | £345,465 | £93,715 | £136,801 | £37,777 | £89,412 |
| Assets less current liabilities | £2,773,629 | £1,927,643 | £1,545,068 | £947,517 | £616,919 | £295,213 | £534,912 | £281,161 | £216,927 |
| People & pay | |||||||||
| Average employees | 31 | 24 | 21 | 16 | 12 | 15 | 14 | 8 | 4 |
| Source evidence | View filing | View filing | View filing | View filing | View filing | View filing | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesNo charges available in our records.
Scaleup signal
OECD growth threshold met
25% employee CAGR